PCI’s 8th Annual Celebration of Innovation Honors Research and Commercialization Accomplishments at Penn
On December 5th, 2023, PCI hosted its annual Celebration of Innovation, where special awards were presented for exceptional commercialization accomplishments and to celebrate Penn innovators.
PCI Hosts IvyTech 2023
The goal was to discuss various topics related to technology commercialization, startup company formation, and building relationships between academia and the commercial sector.
Penn Hosts IvyTech 2023 – Event Recap
Last week, PCI hosted IvyTech, an annual conference that brings together technology transfer professionals to discuss the future of research, commercialization, and intellectual property.
PCI and Penn Medicine Represent at PHILLY BUILDS BIO+: 2ND ANNUAL SYMPOSIUM FOR LIFE SCIENCE INNOVATION AND DEVELOPMENT
Jon Epstein was keynote speaker and Ben Dibling served on a panel discussing science and technology in the context of accelerating innovation.
Penn Faculty Discover an Innovative Potential Treatment for Tooth Decay
The study provides a potential solution for dental caries, also known as tooth decay.
Commercialization Speaker Series Engages Penn Faculty, Researchers, and Students
The the Penn Center for Innovation, along with Penn Engineering and Penn Medicine, presented speaker sessions with experts in the field.
Quantum Technology Innovation at Penn Engineering Receives Major Boost through Multi-Year Collaboration with Quantum Motion Technologies
Quantum Motion Technologies Ltd., a privately held company in London, UK, entered into an R&D collaboration agreement with Penn.
Penn Engineering and AlphaThera Expand License Agreement
AlphaThera, a startup company co-founded by Andrew Tsourkas, PhD, entered into an expanded license agreement with Penn.
PCI Attends 2023 BIO International Convention
Qishui (Tracy) Chen, Assistant Director of Licensing, Physical Sciences, and Engineering shared and discussed a wide range of available drug delivery technologies come out of Penn.
PCI Participates in Cellicon Valley ’23: The Future of Cell and Gene Therapies
Three staff members spoke at Track 5: “$tuff You Should Know about Starting Up and Spinning Out a Cell and Gene Biotech.”